DK3191457T3 - BENZOIMIDAZOL-1,2-YL AMIDER SOM Kv7-KANALAKTIVATORER - Google Patents
BENZOIMIDAZOL-1,2-YL AMIDER SOM Kv7-KANALAKTIVATORER Download PDFInfo
- Publication number
- DK3191457T3 DK3191457T3 DK15840730.4T DK15840730T DK3191457T3 DK 3191457 T3 DK3191457 T3 DK 3191457T3 DK 15840730 T DK15840730 T DK 15840730T DK 3191457 T3 DK3191457 T3 DK 3191457T3
- Authority
- DK
- Denmark
- Prior art keywords
- benzoimidazole
- amides
- channel activators
- activators
- channel
- Prior art date
Links
- 239000012190 activator Substances 0.000 title 1
- 150000001408 amides Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462050023P | 2014-09-12 | 2014-09-12 | |
| PCT/US2015/050027 WO2016040952A2 (en) | 2014-09-12 | 2015-09-14 | BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3191457T3 true DK3191457T3 (da) | 2019-10-07 |
Family
ID=55454102
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19185319.1T DK3572405T3 (da) | 2014-09-12 | 2015-09-14 | Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer |
| DK15840730.4T DK3191457T3 (da) | 2014-09-12 | 2015-09-14 | BENZOIMIDAZOL-1,2-YL AMIDER SOM Kv7-KANALAKTIVATORER |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19185319.1T DK3572405T3 (da) | 2014-09-12 | 2015-09-14 | Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer |
Country Status (14)
| Country | Link |
|---|---|
| US (6) | US9481653B2 (da) |
| EP (3) | EP4289822A3 (da) |
| DK (2) | DK3572405T3 (da) |
| ES (2) | ES2749103T3 (da) |
| FI (1) | FI3572405T3 (da) |
| HR (1) | HRP20231071T1 (da) |
| HU (1) | HUE064331T2 (da) |
| LT (1) | LT3572405T (da) |
| PL (1) | PL3572405T3 (da) |
| PT (1) | PT3572405T (da) |
| RS (1) | RS64708B1 (da) |
| SI (1) | SI3572405T1 (da) |
| SM (1) | SMT202300362T1 (da) |
| WO (2) | WO2016040952A2 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2970277B1 (en) * | 2013-03-15 | 2021-07-28 | Knopp Biosciences LLC | Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators |
| HRP20231071T1 (hr) * | 2014-09-12 | 2024-03-01 | Biohaven Therapeutics Ltd. | Benzoimidazol-1,2-il amidi kao aktivatori kv7 kanala |
| PL3755684T3 (pl) * | 2018-02-20 | 2023-11-06 | H. Lundbeck A/S | Pochodne alkoholowe jako substancje otwierające kanał potasowy kv7 |
| US10590067B2 (en) | 2018-02-20 | 2020-03-17 | H. Lundbeck A/S | Alcohol derivatives of carboxamides as Kv7 potassium channel openers |
| KR20240163771A (ko) * | 2018-03-19 | 2024-11-19 | 놉 바이오사이언시스 엘엘씨 | Kv7 채널 활성화제 조성물 및 이의 사용 방법 |
| AR119521A1 (es) | 2019-08-02 | 2021-12-22 | H Lundbeck As | DERIVADOS DE ALCOHOL COMO ABRIDORES DEL CANAL DE POTASIO Kv7 |
| BR112021006324A2 (pt) * | 2019-08-02 | 2022-02-15 | H Lundbeck As | Derivados de álcool como abridores de canal de potássio kv7 |
| US20220227716A1 (en) * | 2019-08-28 | 2022-07-21 | Ferro Therapeutics, Inc. | Benzimidazole and hydrogenated carbazole derivatives as gpx4 inhibitors |
| PH12022550594A1 (en) | 2019-09-17 | 2023-11-29 | Biohaven Therapeutics Ltd | Methods of use for kv7 channel activators |
| CN118510777A (zh) * | 2022-01-07 | 2024-08-16 | 拜奥海芬治疗学有限公司 | 作为Kv7通道激活剂的吡唑并[1,5-A]吡啶-2,3-基酰胺 |
| IL318953A (en) * | 2022-09-06 | 2025-04-01 | Biohaven Therapeutics Ltd | Combination treatments including metal channel activators |
| WO2025103406A1 (zh) * | 2023-11-15 | 2025-05-22 | 南京明德新药研发有限公司 | 6并5杂芳基衍生物及其应用 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1022554A (en) | 1973-03-07 | 1977-12-13 | Haukur Kristinsson | 1-carbamoyl-2-alkoxycarbonylaminoimidazo (4,5-b) pyridines |
| US4002623A (en) | 1974-08-07 | 1977-01-11 | Pfizer Inc. | Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines |
| ES473201A1 (es) | 1977-09-26 | 1979-03-16 | Degussa | Procedimiento para la preparacion de 7-azabencimidazoles |
| US4391811A (en) | 1981-10-02 | 1983-07-05 | Sterling Drug Inc. | 2-Amino-6-(pyridinyl)-3H-imidazo[4,5-b]pyridines and their cardiotonic use |
| JPH0772181B2 (ja) * | 1989-06-26 | 1995-08-02 | 株式会社大塚製薬工場 | ベンズイミダゾール誘導体 |
| JPH0772181A (ja) | 1993-09-03 | 1995-03-17 | Advantest Corp | 電位波形測定方法および装置 |
| GB9413724D0 (en) * | 1994-07-07 | 1994-08-24 | Wellcome Found | Therapeutic nucleosides |
| NZ503432A (en) | 1997-09-26 | 2002-11-26 | Zentaris Gmbh | Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function |
| US20030109549A1 (en) * | 1999-08-05 | 2003-06-12 | Fumitaka Ito | 2-Substituted-1-piperidyl benzimidazole compounds as ORL1-receptor agonists |
| JP2001199968A (ja) | 2000-01-18 | 2001-07-24 | Teijin Ltd | アミノベンズイミダゾール誘導体 |
| US6384049B1 (en) | 2000-05-25 | 2002-05-07 | The Procter & Gamble Company | Cancer treatment |
| US6855714B2 (en) | 2001-07-06 | 2005-02-15 | Schering Aktiengesellschaft | 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
| FR2846656B1 (fr) | 2002-11-05 | 2004-12-24 | Servier Lab | Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| SE0301701D0 (sv) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| WO2005021547A2 (en) | 2003-08-28 | 2005-03-10 | Pharmaxis Pty Ltd. | Heterocyclic cannabinoid cb2 receptor antagonists |
| US20080039442A1 (en) | 2004-12-21 | 2008-02-14 | Devgen Nv | Compounds With Kv4 Ion Channel Activity |
| WO2007022305A2 (en) | 2005-08-16 | 2007-02-22 | Pharmacopeia, Inc. | 2-aminoimidazopyridines for treating neurodegenerative diseases |
| ES2274712B1 (es) | 2005-10-06 | 2008-03-01 | Laboratorios Almirall S.A. | Nuevos derivados imidazopiridina. |
| EP2186804B1 (en) * | 2007-08-10 | 2015-06-17 | Nippon Soda Co., Ltd. | Nitrogen-containing heterocyclic compound and pest control agent |
| US8058274B2 (en) | 2007-08-17 | 2011-11-15 | Icagen, Inc. | Heterocycles as potassium channel modulators |
| DK2409975T3 (da) * | 2007-11-22 | 2015-08-03 | Zenyaku Kogyo Kk | Faste dispersioner omfattende et amorf legeme bestående af en heterocyklisk anti-tumor-forbindelse |
| GB0723794D0 (en) | 2007-12-05 | 2008-01-16 | Lectus Therapeutics Ltd | Potassium ion channel modulators and uses thereof |
| AU2008343813B2 (en) * | 2007-12-19 | 2012-04-12 | Amgen Inc. | Inhibitors of PI3 kinase |
| WO2010051819A1 (en) * | 2008-11-10 | 2010-05-14 | Neurosearch A/S | Novel 2,3-diamino-quinazolinone derivatives and their medical use |
| MX2011006509A (es) * | 2008-12-19 | 2011-10-19 | Genentech Inc | Compuestos heterociclicos y métodos de uso. |
| WO2010094645A1 (en) | 2009-02-17 | 2010-08-26 | Neurosearch A/S | Substituted pyridine derivatives and their medical use |
| MX2012005100A (es) | 2009-10-29 | 2012-06-08 | Palau Pharma Sa | Derivados de heteroarilo que contienen n como inhibidores de cinasa jak3. |
| WO2012003576A1 (en) | 2010-07-06 | 2012-01-12 | Université de Montréal | Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators |
| WO2012004698A1 (en) * | 2010-07-08 | 2012-01-12 | Pfizer Inc. | Piperidinyl pyrimidine amides as kv7 potassium channel openers |
| RU2013109143A (ru) * | 2010-08-05 | 2014-09-10 | Амджен Инк. | Бензимидазол- и азабензимидазолсодержащие соединения, которые ингибируют киназу анапластической лимфомы |
| EP2970277B1 (en) | 2013-03-15 | 2021-07-28 | Knopp Biosciences LLC | Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators |
| HRP20231071T1 (hr) | 2014-09-12 | 2024-03-01 | Biohaven Therapeutics Ltd. | Benzoimidazol-1,2-il amidi kao aktivatori kv7 kanala |
| KR20240163771A (ko) * | 2018-03-19 | 2024-11-19 | 놉 바이오사이언시스 엘엘씨 | Kv7 채널 활성화제 조성물 및 이의 사용 방법 |
| PH12022550594A1 (en) * | 2019-09-17 | 2023-11-29 | Biohaven Therapeutics Ltd | Methods of use for kv7 channel activators |
-
2015
- 2015-09-14 HR HRP20231071TT patent/HRP20231071T1/hr unknown
- 2015-09-14 DK DK19185319.1T patent/DK3572405T3/da active
- 2015-09-14 RS RS20230951A patent/RS64708B1/sr unknown
- 2015-09-14 EP EP23182255.2A patent/EP4289822A3/en active Pending
- 2015-09-14 DK DK15840730.4T patent/DK3191457T3/da active
- 2015-09-14 PT PT191853191T patent/PT3572405T/pt unknown
- 2015-09-14 ES ES15840730T patent/ES2749103T3/es active Active
- 2015-09-14 PL PL19185319.1T patent/PL3572405T3/pl unknown
- 2015-09-14 FI FIEP19185319.1T patent/FI3572405T3/fi active
- 2015-09-14 HU HUE19185319A patent/HUE064331T2/hu unknown
- 2015-09-14 WO PCT/US2015/050027 patent/WO2016040952A2/en active Application Filing
- 2015-09-14 ES ES19185319T patent/ES2960991T3/es active Active
- 2015-09-14 US US14/853,815 patent/US9481653B2/en active Active
- 2015-09-14 SM SM20230362T patent/SMT202300362T1/it unknown
- 2015-09-14 SI SI201531964T patent/SI3572405T1/sl unknown
- 2015-09-14 EP EP15840730.4A patent/EP3191457B1/en active Active
- 2015-09-14 EP EP19185319.1A patent/EP3572405B9/en active Active
- 2015-09-14 LT LTEP19185319.1T patent/LT3572405T/lt unknown
-
2016
- 2016-10-31 US US15/339,590 patent/US9914708B2/en active Active
-
2017
- 2017-10-31 WO PCT/US2017/059393 patent/WO2018081825A1/en active Application Filing
-
2018
- 2018-01-25 US US15/879,792 patent/US10385025B2/en active Active
-
2019
- 2019-07-02 US US16/460,449 patent/US10906877B2/en active Active
-
2020
- 2020-12-18 US US17/127,231 patent/US11834418B2/en active Active
-
2023
- 2023-10-20 US US18/490,942 patent/US12351559B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3191457T3 (da) | BENZOIMIDAZOL-1,2-YL AMIDER SOM Kv7-KANALAKTIVATORER | |
| DK3744714T3 (da) | (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepan-2-carboxamider som dipeptidylpeptidase i-hæmmere | |
| EP3183346C0 (en) | CHANNEL MODULATORS | |
| LT3230281T (lt) | 1,3-tiazol-2-ilu pakeisti benzamidai | |
| BR112017000446A2 (pt) | arranjos de estação de acionamento | |
| DK3352625T3 (da) | Reorganiserbar liggestol til flere formål, flere anvendelser | |
| BR112017012364A2 (pt) | pré-tratamento rápido. | |
| CL2014003447S1 (es) | Refrigerador. | |
| ZA201703498B (en) | Kcnq2-5 channel activator | |
| EP3102364C0 (en) | CLAMPING DEVICE | |
| LT3253749T (lt) | Junginiai, pasižymintys priešnavikiniu aktyvumu | |
| DK3250774T3 (da) | Port, især hurtigt løbende port | |
| EP3146119C0 (de) | Pneumatischer träger | |
| EP3284795A4 (en) | NUCLEAR ACTIVATOR WITH FREEZER PROTECTION | |
| HK40102357A (en) | Benzoimidazol-1,2-yl amides as kv7 channel activators | |
| EP3181780C0 (de) | Versorgungsrinne | |
| LT3110812T (lt) | Anti-amiloidų junginiai, turintys benzofurazano | |
| TH1601002634B (th) | เครื่องติดฉลาก | |
| TH1401007721B (th) | เครื่องพิมพ์ | |
| ES1109257Y (es) | Canaleta antivandalica | |
| TH1601003501B (th) | ตู้เย็น | |
| TH1601003064B (th) | ตู้เย็น | |
| TH1501007026B (th) | เครื่องมือสำหรับความงาม | |
| TH1601002676B (th) | ชิ้นส่วนรองลื่นเเบบเลื่อน | |
| TH1601000135B (th) | ตู้เย็น |